Role of nintedanib in the treatment of progressive pulmonary fibrosis (PPF) in daily clinical practice.

被引：0
|
作者：
Andres Franch, Fatima [1 ]
Alvarez Martinez, Ignacio Salvador [2 ]
Andujar Llamazares, Mario [3 ]
Segura Ayala, Daniel [3 ]
Meneses Petersen, Elsie Daviana [1 ]
Cabanes Lopez, Luis [1 ]
Novella Sanchez, Laura [1 ]
Ferrando Gabarda, Jose Ramon [1 ]
Meseguer Sisternes, Maria [1 ]
Lluch Tortajada, Inmaculada [1 ]
Naval Sendra, Elsa [1 ]
机构：
[1] Hosp Univ La Ribera, Resp Med Unit, Alzira, Valencia, Spain
[2] Hosp Univ La Ribera, Internal Med Unit, Alzira, Valencia, Spain
[3] Hosp Gen Univ Castellon, Resp Med Unit, Castellon de La Plana, Spain
来源：
EUROPEAN RESPIRATORY JOURNAL | 2023年 / 62卷
关键词：
D O I：
10.1183/13993003.congress-2023.PA407
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Effect of Nintedanib in Patients with Progressive Pulmonary Fibrosis in Subgroups with Differing Baseline Characteristics
    Martin Kolb
    Kevin R. Flaherty
    Rafael S. Silva
    Antje Prasse
    Carlo Vancheri
    Heiko Mueller
    Kamila Sroka-Saidi
    Athol U. Wells
    Advances in Therapy, 2023, 40 : 5536 - 5546
  • [42] Pirfenidone And Nintedanib For Pulmonary Fibrosis In Real-World Clinical Practice: Tolerability And Adverse Drug Reactions
    Galli, J. A.
    Pandya, A.
    Vega-Olivio, M.
    Criner, G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [43] Continued Nintedanib Treatment in Patients with Progressive Pulmonary Fibrosis Related to Autoimmune Disease: Data from INBUILD- ON
    Matteson, Eric
    Antin-Ozerkis, Danielle
    Bonella, Francesco
    Chaudhuri, Nazia
    Cottin, Vincent
    Mueller, Heiko
    Sambevski, Steven
    Wuyts, Wim A.
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 4260 - 4262
  • [44] Efficacy and Safety of Nintedanib for the Treatment of Idiopathic Pulmonary Fibrosis: An Update
    Antonio Rodriguez-Portal, Jose
    DRUGS IN R&D, 2018, 18 (01) : 19 - 25
  • [45] Initial clinical experience with nintedanib for treatment of idiopathic pulmonary fibrosis (IPF): About 20 cases
    Valenzuela, Claudia
    Molina, Maria
    Diaz Chantar, Fatima
    Alonso, Tamara
    Rodriguez Portal, Jose Antonio
    Rodriguez Nieto, Maria Jesus
    Laporta, Rosalia
    Jesus Linares, Maria
    Ancochea, Julio
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [46] Safety of nintedanib added to pirfenidone treatment for idiopathic pulmonary fibrosis
    Flaherty, Kevin R.
    Fell, Charlene D.
    Huggins, J. Terrill
    Nunes, Hilario
    Sussman, Robert
    Valenzuela, Claudia
    Petzinger, Ute
    Stauffer, John L.
    Gilberg, Frank
    Bengus, Monica
    Wijsenbeek, Marlies
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52 (02)
  • [47] NINTEDANIB IN TREATMENT OF PULMONARY FIBROSIS SECONDARY TO CONNECTIVE TISSUE DISEASE
    Laria, A.
    Lurati, A. M.
    Mazzocchi, D.
    Re, K.
    Marrazza, M. G.
    Zaccara, E.
    Bompane, D.
    Tamburello, A.
    Castelnovo, L.
    Bini, F.
    Faggioli, P. M.
    Mazzone, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1449 - 1449
  • [48] Nintedanib treatment for pulmonary fibrosis after coronavirus disease 2019
    Ogata, Hiroaki
    Nakagawa, Taisuke
    Sakoda, Soichiro
    Ishimatsu, Akiko
    Taguchi, Kazuhito
    Kadowaki, Masako
    Moriwaki, Atsushi
    Yoshida, Makoto
    RESPIROLOGY CASE REPORTS, 2021, 9 (05):
  • [49] Combination treatment with nintedanib and prednisolone for patients with idiopathic pulmonary fibrosis
    Kato, Motoyasu
    Nakamura, Takahiro
    Kono, Kana
    Haraguchi, Mizuki
    Yamada, Tomoko
    Ihara, Hiroaki
    Takahashi, Fumiyuki
    Takahashi, Kazuhisa
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [50] Thrombocytopaenia during nintedanib treatment in a patient with idiopathic pulmonary fibrosis
    Ochi, Yusuke
    Kato, Motoyasu
    Fujioka, Masahiro
    Hayashi, Mika
    Takagi, Haruhi
    Takahashi, Kazuhisa
    RESPIROLOGY CASE REPORTS, 2020, 8 (07):
12345